As depicted in Figure 3(c), the SHR action targets in treating GERD were mainly related to the pathways enriched by Leishmania infection, Chagas disease (American trypanosomiasis), pertussis, IL-17 signaling pathway, and Th17 cell differentiation. The gene discussed is IL17A; the disease is Chagas disease.